2017•Zhongguo yiyuan ganranxue zazhiRequires access

Pharmacoeconomics on treatment of Gram-negative bacteria infections with cefoperazone-sulbactam, imipenem-cilastatin, and piperacillin-tazobactam.

Tang KeJing, Yifeng Luo, Xia Su, He Bei, Guochao Shi, Song Li-qiang, Fuqiang Wen, Lyu XiaoJu, Baiyi Chen, Shengdao Xiong, Jianping Zhao, Tiantuo Zhang, Zhou Jianying, Yunsong Yu, Bin Cao, Xiao Wei, Pan PinHua, Yi Ping Shi, Lin QiChang, Yiqiang Chen, NI Yu-xing, Xie Can-mao

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Sulbactam, Cefoperazone, Piperacillin, Piperacillin/tazobactam, Tazobactam, Microbiology, Medicine, Imipenem